Shares of Omron Corp. (OTCMKTS:OMRNY – Get Free Report) shot up 7.8% during mid-day trading on Tuesday. The company traded as high as $32.40 and last traded at $31.92. 38,773 shares were traded during trading, a decline of 12% from the average session volume of 44,052 shares. The stock had previously closed at $29.62.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a report on Monday, August 10th. Two equities research analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Omron currently has an average rating of “Hold”.
Check Out Our Latest Stock Analysis on OMRNY
Omron Stock Performance
The firm has a market cap of $6.42 billion, a PE ratio of 29.65, a P/E/G ratio of 0.60 and a beta of 1.29. The firm has a 50-day moving average price of $37.40 and a two-hundred day moving average price of $34.81. The company has a quick ratio of 1.49, a current ratio of 1.93 and a debt-to-equity ratio of 0.09.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC raised its position in Omron Corp. (OTCMKTS:OMRNY – Free Report) by 12.1% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,536 shares of the company’s stock after purchasing an additional 382 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $144,000 at the end of the most recent quarter. Institutional investors own 1.09% of the company’s stock.
Omron Company Profile
Omron Corporation is a Japanese technology company that develops and manufactures automation, healthcare, and electronic products. Founded in 1933 by Kazuma Tateishi, the company began as an electronics manufacturer and has since expanded into a range of industrial and consumer markets. Omron’s industrial automation business provides equipment and systems such as sensors, controllers, robotics, and inspection devices for manufacturing and other operations. Its healthcare products include blood pressure monitors, thermometers, and respiratory-care devices, while its social systems business supplies technologies for areas such as transportation and energy management.
Further Reading
- Five stocks we like better than Omron
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
